Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes.

The oncologist

Volumn 16 Suppl 3, Issue , 2011, Pages 35-42

  Santini, Valeria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANEMIA; HUMAN; MYELODYSPLASTIC SYNDROME; REVIEW;

ANEMIA; ERYTHROPOIETIN; HEMATINICS; HUMANS; MYELODYSPLASTIC SYNDROMES; RECOMBINANT PROTEINS;

EID: 84856001005     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-S3-35     Document Type: Review

References (0)